Skip to content
Screener

Zimmer Biomet Holdings ZBH Other Non-Current Assets

Other Non-Current Assets at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$14.27B
PDE
Pro-Dex, Inc.PDEX
$60K+36.4%
CONMED logo
CONMEDCNMD
$153.18M+5.6%
Vericel logo
VericelVCEL
$233K-47.9%
Anika Therapeutics logo
Anika TherapeuticsANIK
$3.02M-45.5%
Globus Medical logo
Globus MedicalGMED
$79.24M+5.9%

Other financials

Income statement

See full
Revenue$2.2B+4.8%
Gross profit$1.5B+3.8%
Operating income$326.1M+8.7%
Net income$198.3M+29.8%
EPS (diluted)$1.03+33.8%

Balance sheet

See full
Cash & equivalents$410.0M-26.4%
Total debt$7.5B-1.2%
Total equity$12.6B+0.8%
Total assets$22.8B-0.3%

Cash flow

See full
Operating cash flow$447.8M+18.4%
CapEx$54.2M+8.2%
Free cash flow$393.6M+20.0%

Valuation

See full
Market cap$18.99B+5.3%
Enterprise value$26.06B+4.0%
P/E23.5×+1.6×
P/S2.2×-0.1×

Profitability

See full
Gross margin69.9%-1.2pp
Operating margin14.2%-1.9pp
Net margin9.5%-1.0pp
FCF margin17.9%-0.9pp

Returns & leverage

See full
Return on equity6.4%-0.1pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.2×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Zimmer Biomet Holdings’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335044
Line itemJune 30, 2026December 31, 2025
Property, plant and equipment, net2,236.82,207.1
Goodwill9,919.59,947.1
Intangible assets, net4,461.64,717.3
Other assets1,083.31,100.3
Total Assets$22,797.8$23,091.7
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts payable$352.4$303.0

Item 1. Financial Statements

FAQ

What is Zimmer Biomet Holdings's other non-current assets?
Zimmer Biomet Holdings (ZBH) reported other non-current assets of $1.08B in Q2 2026.
How has Zimmer Biomet Holdings's other non-current assets changed year-over-year?
Zimmer Biomet Holdings's other non-current assets increased by 4.6% year-over-year, from $1.04B to $1.08B.
What is the long-term trend for Zimmer Biomet Holdings's other non-current assets?
Over 5 years (2020 to 2025), Zimmer Biomet Holdings's other non-current assets has grown at a 2.6% compound annual growth rate (CAGR), from $969.4M to $1.1B.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Zimmer Biomet Holdings's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude